Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€416.00
06.02.21
-
06.02.22
7.91%
25.05.21

EBIT growth >5% per year expected
Very low/no dividend yield expected
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€416.00
06.02.21
-
06.02.22
7.91%
25.05.21

EBIT growth >5% per year expected
Very low/no dividend yield expected
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€416.00
06.02.21
-
06.02.22
7.91%
25.05.21

EBIT growth >5% per year expected
Very low/no dividend yield expected
Fifth Third Bancorp

Start price
Target price
Perf. (%)
€26.60
06.02.21
-
06.02.22
41.35%
13.12.21

Very high dividend yield expected
Business model of the past or high risk
Higher risks for its business
Fifth Third Bancorp

Start price
Target price
Perf. (%)
€26.60
06.02.21
-
06.02.22
41.35%
13.12.21

Very high dividend yield expected
Business model of the past or high risk
Higher risks for its business
buy
Microstrateg.a New

Start price
Target price
Perf. (%)
€690.00
06.02.21
€1,400.0
06.02.22
-14.42%
07.10.21

buy
Westport Innovations Inc.

Start price
Target price
Perf. (%)
€9.50
06.02.21
€2.00
01.07.22
-86.18%
20.02.22

Innovative
Differentiated customer and product portfolio
Known brand
Very Future proof/growth oriented business model
buy
Akamai Tech.

Start price
Target price
Perf. (%)
€96.06
06.02.21
-
06.02.22
-14.44%
11.03.21

Could be worthwhile Investment >10% per year
buy
Akamai Tech.

Start price
Target price
Perf. (%)
€96.06
06.02.21
-
06.02.22
-14.44%
11.03.21

Could be worthwhile Investment >10% per year
buy
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€38.55
06.02.21
-
06.02.22
30.17%
09.02.21

Could be very worthwhile Investment >20% year
buy
Astrotech Corp.

Start price
Target price
Perf. (%)
€2.34
06.02.21
-
06.02.22
27.35%
11.02.21

Could be worthwhile Investment >10% per year
buy
DAVIDsTEA Inc

Start price
Target price
Perf. (%)
€4.18
06.02.21
-
06.02.22
-37.32%
07.02.22

Could be worthwhile Investment >10% per year
buy
T2 Biosystems Inc.

Start price
Target price
Perf. (%)
€137.50
06.02.21
-
06.02.22
-10.00%
19.02.21

Could be very worthwhile Investment >20% year
Coca-Cola Co.

Start price
Target price
Perf. (%)
€41.14
05.02.21
-
4.28%
21.03.21

Risky Investment
Coca-Cola Co.

Start price
Target price
Perf. (%)
€41.14
05.02.21
-
4.28%
21.03.21

Risky Investment
buy
Apple Inc.

Start price
Target price
Perf. (%)
€113.52
05.02.21
€115.00
12.02.22
39.90%
28.12.21

Could be very worthwhile Investment >20% year
Good culture
Capable Management
buy
Apple Inc.

Start price
Target price
Perf. (%)
€113.52
05.02.21
€115.00
12.02.22
39.90%
28.12.21

Could be very worthwhile Investment >20% year
Good culture
Capable Management
buy
Apple Inc.

Start price
Target price
Perf. (%)
€113.52
05.02.21
€115.00
12.02.22
39.90%
28.12.21

Could be very worthwhile Investment >20% year
Good culture
Capable Management
buy
Apple Inc.

Start price
Target price
Perf. (%)
€113.52
05.02.21
€115.00
12.02.22
39.90%
28.12.21

Could be very worthwhile Investment >20% year
Good culture
Capable Management
Tesla Inc

Start price
Target price
Perf. (%)
€238.00
05.02.21
€238.00
-10.36%
21.02.21

Risky Investment
Tesla Inc

Start price
Target price
Perf. (%)
€238.00
05.02.21
€238.00
-10.36%
21.02.21

Risky Investment
T2 Biosystems Inc.

Start price
Target price
Perf. (%)
€132.95
05.02.21
€100.00
-10.68%
21.02.21

Risky Investment
buy
Bayer AG

Start price
Target price
Perf. (%)
€56.11
05.02.21
€90.00
05.02.22
-5.54%
05.02.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Bayer AG

Start price
Target price
Perf. (%)
€56.11
05.02.21
€90.00
05.02.22
-5.54%
05.02.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€138.90
05.02.21
-
31.12.21
0.09%
29.03.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative